Investigation of the pyrazinones as PDE5 inhibitors: Evaluation of regioisomeric projections into the solvent region.
Hughes, R.O., Maddux, T., Joseph Rogier, D., Lu, S., Walker, J.K., Jon Jacobsen, E., Rumsey, J.M., Zheng, Y., Macinnes, A., Bond, B.R., Han, S.(2011) Bioorg Med Chem Lett 21: 6348-6352
- PubMed: 21955943 
- DOI: https://doi.org/10.1016/j.bmcl.2011.08.106
- Primary Citation of Related Structures:  
3TGE, 3TGG - PubMed Abstract: 
We describe the design, synthesis and profiling of a novel series of PDE5 inhibitors. We take advantage of an alternate projection into the solvent region to identify compounds with excellent potency, selectivity and pharmacokinetic profiles.
Organizational Affiliation: 
Pfizer Global Research and Development, 700 Chesterfield Parkway West, St. Louis, MO 63017, USA. robowenhughes@gmail.com